Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER
In 1996, the Ministers of Health of Egypt, Israel, Jordan, Cyprus, and the Palestinian Authority (PA) signed an agreement to establish the Middle East Cancer Consortium (MECC). Turkey joined the Consortium in 2004. This is the first comprehensive publication of the MECC Cancer Registration Project. The monograph presents information about cancer incidence for populations in Cyprus, Egypt (Gharbiah Region), Israel (Jews and Arabs), and Jordan for the period 1996-2001. The MECC findings are compared with those from the US Surveillance, Epidemiology, and End Results (SEER) Program.
The monograph is provided in Portable Document Format (PDF). You may also order a printed copy of the book.
Monograph Chapters (PDF Files)
- Table of Contents - 207 KB
- Preface and Executive Summary - 720 KB
- Overview and Summary Data - 644 KB
- Esophageal Cancer - 322 KB
- Stomach Cancer - 319 KB
- Colorectal Cancer - 451 KB
- Liver and Intrahepatic Bile Duct Cancer - 351 KB
- Lung Cancer - 279 KB
- Laryngeal Cancer - 276 KB
- Breast Cancer - 389 KB
- Cervical and Corpus Uterine Cancer - 393 KB
- Ovarian Cancer - 370 KB
- Urinary Bladder Cancer - 829 KB
- Brain and Other Central Nervous System Cancer - 419 KB
- Thyroid Cancer - 449 KB
- Lymphoma and Leukemia - 353 KB
- Childhood Cancer - 425 KB
- Acknowledgments, Editors and Contributors - 168 KB
Download monograph in single PDF file -3.4 MB
Suggested Citation
Freedman LS, Edwards BK, Ries LAG, Young JL (eds). Cancer Incidence in Four Member Countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) Compared with US SEER. National Cancer Institute, 2006. NIH Pub. No. 06-5873. Bethesda, MD.
Citation for a chapter should also include the chapter authors and chapter title.
Copyright Information
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.